ArticleJournal of clinical laboratory analysis2022

CEBPB regulates the bile acid receptor FXR to accelerate colon cancer progression by modulating aerobic glycolysis.

Zhengrong Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.